Cargando…

Efficiency of HIV-1 PR-RT genotyping is not impacted by co-infection with HCV

Detalles Bibliográficos
Autores principales:	Deloof, ACA, De Wolf, H, Verlinden, Y, Villacian, J, Pattery, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The International AIDS Society 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112997/ http://dx.doi.org/10.1186/1758-2652-13-S4-P212

Ejemplares similares

Effect of lipemia and bilirubinemia on HIV-1 protease and reverse transcriptase genotyping and phenotyping success: a five-year analysis
por: Pattery, T, et al.
Publicado: (2010)

Changing prevalence of darunavir resistance-associated mutations (DRV RAMs) in clinical samples received for routine resistance testing: 2003-2009
por: De La Rosa, G, et al.
Publicado: (2010)

Oral administration of a mixture of PR, RT and INT inhibitors to rhesus macaques that were persistently infected with SHIV-pr
por: Ido, Eiji, et al.
Publicado: (2009)

The results of a study on the prevalence of HIV, HCV and HBV genotypes in some regions of Ukraine
por: Yurchenko, et al.
Publicado: (2012)

HBV and HCV genotypes distribution on the territory of Belarus
por: Gasich, EL, et al.
Publicado: (2012)

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
por: Conway, B, et al.
Publicado: (2010)

Immune response characterization in HIV/HCV co-infected patients of medicine tropical foundation
por: Malheiro, Adriana, et al.
Publicado: (2010)

Behavioral factors associated with HCV and HIV co-infection in residents of São Paulo, Brazil
por: Farias, Norma, et al.
Publicado: (2012)

Low reduction of HCV-RNA level at week 4 in HIV-1 infected patients with acute HCV Infection
por: Vincent, A, et al.
Publicado: (2012)

Spontaneous HCV clearance in a patient with HIV infection and a concurrent, never treated, evolutive HCV hepatitis, after over twenty years of chronic co-infection
por: Manfredi, Roberto, et al.
Publicado: (2010)

Liver disease progression in HIV/HCV co-infected patients: a role for metalloproteinases and their specific inhibitors
por: Sasongko, Priyo
Publicado: (2006)

No impact of IL28B polymorphisms on liver enzymes in patients coinfected with HIV and HCV
por: Fernández-Montero, JV, et al.
Publicado: (2010)

Novel acyclic nucleoside analogues as inhibitors of HIV-1 RT
por: Singh, Anuradha, et al.
Publicado: (2012)

Prevalence of HCV, HBV and HIV infections in patients and staff of haemodialysis unit
por: Palanisamy, Saraswathy, et al.
Publicado: (2012)

Pilot trial of oral therapeutic HIV vaccine, V-1 Immunitor, on HIV and HIV/HCV patients in Russia
por: Bourinbaiar, Aldar, et al.
Publicado: (2010)

Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy
por: Labarga, P, et al.
Publicado: (2010)

Response to treatment of hepatitis C in HCV/HIV co-infected patients is not influenced by either abacavir or tenofovir with weight-based ribavirin
por: Bhatti, L, et al.
Publicado: (2010)

The study of hepatitis B surface antigen and anti-HCV in HIV infected patients
por: Girish, N, et al.
Publicado: (2012)

Transmission of HIV, HBV, HCV in health settings: an anthropological approach on hygiene in Cambodia
por: Hancart-Petitet, Pascale, et al.
Publicado: (2011)

Mitral valve endocarditis in an IV ethnobotanical drug user coinfected with HIV-HCV
por: Popa, Ionut, et al.
Publicado: (2014)

Boceprevir (BOC) and Telaprevir (TPV) therapeutic drug monitoring in HCV and HIV-HCV infected patients treated with triple therapy Ribavirine/Peg-interferon/Boceprevir or Telaprevir: impact of the antiretroviral (ARV) treatment
por: Chantry, AS, et al.
Publicado: (2014)

Role of HCV infection in the development of carotid atherosclerosis in a cohort of HIV-infected patients
por: Ferrara, S, et al.
Publicado: (2010)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

Viral variability study in follow-up sera from HIV-HBV-HCV coninfected patients
por: Taffon, Stefania, et al.
Publicado: (2010)

Validation of astrocytic reference genes for qRT-PCR in CO treatment studies
por: Oliveira, Sara, et al.
Publicado: (2015)

Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) shed light on the mechanism of action of a new Ribonuclease H/ DNA polymerase RT dual inhibitor
por: Corona, Angela, et al.
Publicado: (2013)

Implications of hcv natural genetic diversity on HCV NS5B inhibitor NM283
por: Demetriou, Victoria L, et al.
Publicado: (2010)

Efficacy and safety of TMC278 in treatment-naïve, HIV-1-infected patients with HBV/HCV co-infection enrolled in the phase III ECHO and THRIVE trials
por: Nelson, M, et al.
Publicado: (2010)

Factors associated with HIV and HCV infection among individuals with a history of injection drug use in Baltimore
por: Severtson, SG, et al.
Publicado: (2006)

High prevalence of genotype G in HIV co-infected patients compared with HBV monoinfected patients in México
por: Mata-Marín, JA, et al.
Publicado: (2010)

Genotype testing in HIV-infected pregnant women
por: Afonso, C, et al.
Publicado: (2010)

Effects on insulin sensitivity and hepatic safety of Atazanavir in HCV/HIV coinfected patients versus HIV monoinfected: A prostective 48-week study
por: Meijide, Héctor, et al.
Publicado: (2010)

Changes in immune activation in the T Cell compartments of HIV HCV coinfected patients during PEG IFN RBV treatment
por: Menard, Amélie, et al.
Publicado: (2012)

Impact of Respiration on LV Volume and Function Using rt-MRI
por: Contijoch, Francisco, et al.
Publicado: (2016)

Antiviral resistance in HCV strains isolated from Romanian patients with limited treatment options for chronic HCV infection
por: Streinu-Cercel, Anca, et al.
Publicado: (2014)

The prevalence of RT 245 codon polymorphisms and its association with duration of infection among HIV-1 patients in Serbia
por: Nikolic, Valentina, et al.
Publicado: (2014)

Human papillomavirus (HPV) genotypes among HIV-infected and HIV-uninfected women in Mozambique
por: Lio, Massimo Magnano San, et al.
Publicado: (2010)

P06-02. High prevalences of HIV, HCV, HBV and Treponema pallidum in male and trans sex workers from Argentina
por: Farías, M dos Ramos, et al.
Publicado: (2009)

Efficacy and safety of hepatitis C direct-acting protease inhibitors (DAA-PI ) in real life in HIV-HCV coinfected patients
por: Ménard, A, et al.
Publicado: (2014)

HIV pre-exposure prophylaxis (PrEP)- knowledge and attitudes among a New York City emergency department patient population
por: Calderon, Yvette, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_psqobjhars7eb5lv8ljegsgmkg